Lakefront Biotherapeutics NV is a biotechnology company.
The company combines deal making expertise with capital to identify, acquire, and advance promising opportunities that drive value for patients and shareholders. Applying a modality-agnostic a…
Analysis
Quality compounder
Lakefront Biotherapeutics NV earns the quality_compounder label: good underlying economics priced fairly, with no obvious bargain or excess. Worth noting: the cash the business generates has lagged behind what the income statement shows.
On valuation, the picture is attractive. The owner-earnings multiple stands at 3.2×; owner earnings: the cash an owner could take out each year.
Growth is tepid; the safety picture is sturdy. The company scores 20/20 on our value-creation score: strong value creator. Analyst sentiment is cautious.
Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Mar 20264
42
2026
All-time high
42
Jun 2026
All-time low
4
Mar 2026
Average rank
23
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
5
—
—
—
Price/Earnings
100
—
—
—
Price/Book
90
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
53
—
—
—
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.